ARA-290 is a research peptide designed to selectively activate the innate repair receptor (IRR), a pathway involved in the body's natural tissue repair and inflammatory response. Unlike erythropoietin (EPO), ARA-290 has been investigated for its tissue-protective properties without stimulating red blood cell production.
Researchers have explored ARA-290 for its potential role in nerve health, inflammatory pathways, tissue repair, and cellular protection. It has been studied in models involving peripheral neuropathy, small fiber nerve regeneration, and chronic inflammatory conditions.
ARA-290 is a research peptide designed to selectively activate the innate repair receptor (IRR), a pathway involved in the body's natural tissue repair and inflammatory response. Unlike erythropoietin (EPO), ARA-290 has been investigated for its tissue-protective properties without stimulating red blood cell production.
Researchers have explored ARA-290 for its potential role in nerve health, inflammatory pathways, tissue repair, and cellular protection. It has been studied in models involving peripheral neuropathy, small fiber nerve regeneration, and chronic inflammatory conditions.